Relief of pain of Fabry's disease by diphenylhydantoin.
D000293:Adolescent; D000328:Adult; D001241:Aspirin / Q000627:therapeutic use; D002518:Ceramides / Q000097:blood / Q000652:urine; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D005696:Galactosidases / Q000097:blood; D006017:Glycolipids / Q000378:metabolism*; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010672:Phenytoin / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use
D002518:Ceramides; D006017:Glycolipids; D014815:Vitamins; D010672:Phenytoin; D005696:Galactosidases; D001241:Aspirin